11 research outputs found
Kaplan-Meier survival in the matched cohort.
<p>Kaplan-Meier survival in the matched cohort.</p
Yearly use of BIMA in non-emergent primary isolated CABG during 1997 to 2008 in Sweden.
<p>BIMA = bilateral internal mammary artery, CABG = coronary artery bypass grafting, SIMA = single internal mammary artery.</p
Kaplan-Meier survival in the overall cohort.
<p>Kaplan-Meier survival in the overall cohort.</p
Crude and multivariable adjusted association between BIMA use and all-cause mortality in 49702 patients who underwent non-emergent primary isolated CABG during 1997 to 2008 in Sweden.
<p>Reference category.</p><p>Multivariable adjustment was made for age, gender, estimated glomerular filtration rate, left ventricular ejection fraction, diabetes mellitus, chronic obstructive pulmonary disease, peripheral vascular disease, preoperative myocardial infarction, stroke, heart failure, perioperative acute kidney injury, and the use of cardiopulmonary bypass during surgery.</p><p>BIMA = bilateral internal mammary artery, CABG = coronary artery bypass grafting, CI = confidence interval, HR = hazards ratio, SIMA = single internal mammary artery.</p
BIMA use in non-emergent primary isolated CABG per cardiac surgery center during 1997 to 2008 in Sweden.
<p>BIMA = bilateral internal mammary artery, CABG = coronary artery bypass grafting, SIMA = single internal mammary artery.</p
Baseline characteristics in the propensity score-matched groups (n = 558 in each group) and the standardized differences between the treatment groups.
<p>CABG = Coronary artery bypass grafting, COPD = chronic obstructive pulmonary disease, SD = standard deviation.</p><p>Acute kidney injury was defined as a >0.3 mg/dL (26 µmol/L) increase in postoperative creatinine values.</p
Crude and multivariable adjusted association between BIMA use and a composite endpoint of death or rehospitalization for myocardial infarction, heart failure, or stroke in 49702 patients who underwent primary isolated non-emergent CABG during 1997 to 2008 in Sweden.
<p>Reference category.</p><p>Multivariable adjustment was made for age, gender, estimated glomerular filtration rate, left ventricular ejection fraction, diabetes mellitus, chronic obstructive pulmonary disease, peripheral vascular disease, preoperative myocardial infarction, stroke, heart failure, perioperative acute kidney injury, and the use of cardiopulmonary bypass during surgery.</p><p>BIMA = bilateral internal thoracic artery, CABG = coronary artery bypass grafting, CI = confidence interval, HR = hazards ratio, SIMA = single internal thoracic artery.</p
Cumulative incidence for the composite end-point all-cause mortality or rehospitalization for myocardial infarction, heart failure, or stroke in the overall cohort.
<p>Cumulative incidence for the composite end-point all-cause mortality or rehospitalization for myocardial infarction, heart failure, or stroke in the overall cohort.</p
Cumulative incidence of the composite end-point at 1, 5, and 10 years in the overall and matched cohorts.
<p>Cumulative incidence of the composite end-point at 1, 5, and 10 years in the overall and matched cohorts.</p
Survival at 1, 5, 10, and 13 years in the overall and matched cohorts.
<p>Survival at 1, 5, 10, and 13 years in the overall and matched cohorts.</p